Package 69339-159-17

{"route": ["ORAL"], "spl_id": "2af07b39-fe93-4961-90cb-ed9c5e2f424d", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182141", "N0000185503", "N0000190113"], "upc": ["0369339159019"], "unii": ["304NUG5GF4"], "rxcui": ["348506"], "spl_set_id": ["da63870d-b426-4e49-9591-5bb51f962e66"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]"], "manufacturer_name": ["Natco Pharma USA LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "40 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (69339-159-17)  / 10 mL in 1 CUP, UNIT-DOSE (69339-159-01)", "package_ndc": "69339-159-17", "marketing_start_date": "20220425"}], "brand_name": "Itraconazole Oral", "product_id": "69339-159_2af07b39-fe93-4961-90cb-ed9c5e2f424d", "dosage_form": "SOLUTION", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "69339-159", "generic_name": "Itraconazole", "labeler_name": "Natco Pharma USA LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Itraconazole Oral", "active_ingredients": [{"name": "ITRACONAZOLE", "strength": "10 mg/mL"}], "application_number": "ANDA212239", "marketing_category": "ANDA", "marketing_start_date": "20220425", "listing_expiration_date": "20261231"}